Reprimo (RPRM) as a Potential Preventive and Therapeutic Target for Radiation-Induced Brain Injury via Multiple Mechanisms

• Published in: International journal of molecular sciences Vol. 24; no. 23; p. 17055
• Main Authors: Ye, Zhujing, Wang, Jin, Shi, Wenyu, Zhou, Zhou, Zhang, Yarui, Wang, Jingdong, Yang, Hongying
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.12.2023
• Subjects: Analysis; Apoptosis; Brain; Brain cancer; Brain tumors; Cognition & reasoning; Cognitive ability; Cytotoxicity; DNA damage; Inflammation; Injuries; Investigations; Kinases; microglial activation; Neurogenesis; neuroinflammation; Neurons; Neurophysiology; Oxidative stress; Prevention; Radiation; radiation-induced brain injury; Radiotherapy; RPRM knockout mice; Traumatic brain injury; Tumors; China; radiation-induced brain injury; radiation-induced cognitive impairment; RPRM knockout mice; neuroinflammation; DNA damage; neurogenesis; CCL2; apoptosis; neurons; microglial activation
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms242317055

Patients receiving cranial radiotherapy for primary and metastatic brain tumors may experience radiation-induced brain injury (RIBI). Thus far, there has been a lack of effective preventive and therapeutic strategies for RIBI. Due to its complicated underlying pathogenic mechanisms, it is rather difficult to develop a single approach to target them simultaneously. We have recently reported that Reprimo (RPRM), a tumor suppressor gene, is a critical player in DNA damage repair, and RPRM deletion significantly confers radioresistance to mice. Herein, by using an RPRM knockout (KO) mouse model established in our laboratory, we found that RPRM deletion alleviated RIBI in mice via targeting its multiple underlying mechanisms. Specifically, RPRM knockout significantly reduced hippocampal DNA damage and apoptosis shortly after mice were exposed to whole-brain irradiation (WBI). For the late-delayed effect of WBI, RPRM knockout obviously ameliorated a radiation-induced decline in neurocognitive function and dramatically diminished WBI-induced neurogenesis inhibition. Moreover, RPRM KO mice exhibited a significantly lower level of acute and chronic inflammation response and microglial activation than wild-type (WT) mice post-WBI. Finally, we uncovered that RPRM knockout not only protected microglia against radiation-induced damage, thus preventing microglial activation, but also protected neurons and decreased the induction of CCL2 in neurons after irradiation, in turn attenuating the activation of microglial cells nearby through paracrine CCL2. Taken together, our results indicate that RPRM plays a crucial role in the occurrence of RIBI, suggesting that RPRM may serve as a novel potential target for the prevention and treatment of RIBI.